x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Category: RWE

    Marksman Healthcare > Blog > RWE
Hybrid Study Designs

03Aug

Hybrid Study Designs: Combining Existing and New Data for Valuable Insights

by MarksMan Healthcare,  0 Comments

Hybrid study designs are research methodologies that seamlessly blend elements from multiple study designs to address specific research questions comprehensively. Such a hybrid approach allows researchers to capitalize on the […]

Read More

15May

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

by MarksMan Healthcare,  0 Comments

Real World Evidence (RWE) is generated as a result of the real-world usage of drugs, and thus can complement the RCT (randomized controlled trial) evidence that is generated in controlled […]

Read More

31Mar

The Role and Importance of SLRs and RWE in Drug Price Negotiations in the USA

by MarksMan Healthcare,  0 Comments

The cost of prescription drugs is a significant burden on patients and the healthcare system, especially in countries such as the USA. High drug prices can strain government programs, such […]

Read More

02Jan

The STaRT RWE Template: Improving Reporting of RWE Studies

by MarksMan Healthcare,  0 Comments

Improvements in healthcare digitalization and accelerated regulatory approvals of novel interventions have boosted the possibilities for gathering real-world data (RWD) and using the resultant real-world evidence (RWE) to support the […]

Read More

11Aug

Generating Clinical Evidence From Electronic Health Records and Patient Registries

by MarksMan Healthcare,  0 Comments

Both electronic health records (EHRs) and patient registries store and use patient-related clinical information. However, they are conceptualized for different purposes. Both are a significant source of real-world evidence (RWE) […]

Read More

21Jul

RWE Framework by NICE (UK) for Optimizing RWD Collection and RWE Generation

by MarksMan Healthcare,  0 Comments

Evidence from randomized clinical trials (RCTs) continues to be the standard reference point for treatment efficacy across the world. However, RCTs enrol patients based on strict inclusion and exclusion criteria, […]

Read More

25May

How to Improve Transparency with Real World Data to Support Market Access?

by MarksMan Healthcare,  0 Comments

The USFDA defines real-world data (RWD) as ‘the data relating to patient health status and/or the healthcare delivery that is routinely collected from a variety of sources’, and real-world evidence […]

Read More

23May

Unlocking the Power of RWE: Changing Scenario in the Global Landscape

by MarksMan Healthcare,  0 Comments

There has been a shift in the global healthcare ecosystem from volume-based to value-based payment model, thanks to a surge in data availability, interoperability, advancing health technologies, cost and competitive […]

Read More

21Oct

The Contribution of Wearables Towards Healthcare Evidence Generation

by MarksMan Healthcare,  0 Comments

The health and fitness wearable market is on the rise since the last few years. Analysts expect that by 2020, almost half a billion smart wearable devices will have been […]

Read More

Posts navigation

1 2

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...